Effects of anti-allergic drugs on substance P (SP) and vasoactive intestinal peptide (VIP) in nasal secretions

American Journal of Rhinology

Volumn 11, Issue 3, 1997, Pages 237-241

  Shinoda, Mitsunori ^a   Watanabe, Noritake ^a   Suko, Takeshi ^a   Mogi, Goro ^a   Takeyama, Masaharu ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; AZELASTINE; HOUSE DUST ALLERGEN; OXATOMIDE; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ALLERGY; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; HOUSE DUST; HUMAN; NOSE SECRETION; ORAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0030765921     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/105065897781751901     Document Type: Article

References (26)

1. Unddman R, Sundler F. Innervation of the upper airways. Clin Chest Med 7:201-209, 1986.
2. Lundberg JM, Lundblad L, Martling CR, et al. Coexistence of multiple peptides and classical transmitters in airway neurons: Functional and pathophysiological aspects. Am Rev Respir Dis 136(suppl):S16-S23, 1987.
3. Baraniuk JN, Lundgren JD, Okayama M, et al. Vasoactive in-testinal peptide (VIP) in human nasal mucosa. J Clin Invest 86:825-831, 1990.
4. Karlsson G, Pipkorn U, Andreasson L. Substance P and human mucociliary activity. Eur J Clin Pharmacol 30:355-357, 1986.
5. Miadonna A, Tedeschi A, Leggieri E, et al. Activity of substance P on human skin and nasal airways. Ann Allergy 61:220-223, 1988.
6. Petersson G, McCaffrey TV, Malm L. Substance P and nasal secretion in dog, rat, and man. Ann Allergy 62:410-414, 1989.
7. Stead RH, Bienenstock J, Stanisz A. Neuropeptide regulation of mucosal immunity. Immunol Rev 100:333-359, 1987.
8. Stead RH, Dixon MF, Bramwell NH, et al. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 97:575-585, 1989.
9. Barnes PJ. Asthma as an axon reflex. Lancet 1:242-245, 1986.
10. Chaen T, Watanabe N, Mogi G, et al. Substance P and vasoactive intestinal peptide in nasal secretions and plasma from patients with nasal allergy. Ann Otol Rhinol Laryngol 102:16-21, 1993.
11. Okuda M. Nasal allergy. Tokyo, Japan: Kanehara shuppan Ltd., 1992.
12. Lowry OH, Rosebough NJ, Farr AL, et al. Protein measurement with Folin phenol reagent. J Bio Chem 193:265-275, 1951.
13. Hauser-Kronberger C, Hacker GW, Muss W, et al. Autonomic and peptidergic innervation of human nasal mucosa. Acta Otolaryngol (Stockh) 113:387-393, 1993.
14. Konno A, Togawa K. Role of the vidian nerve in nasal allergy. Ann Otol Rhinol Laryngol 88:258-263, 1979.
15. Konno A, Togawa K, Fujita A. The mechanisms involved in onset of allergic manifestations in the nose. Eur J Respir Dis 64 (Suppl 128):155-166, 1983.
16. Lindberg S, Hybinette J-C, Mercke U. Effects of neuropeptides on mucociliary activity. Ann Otol Rhinol Laryngol 95:94-100, 1986.
17. Khalil Z, Andrews PV, Helme RD. VIP modulates substance P-induced plasma extravasation in vivo. Eur J Pharmacol 151:281-287, 1988.
18. Piostrowski W, Foreman J. On the action of substance P, somatostain, and vasoactive intestinal polypeptide on rat peripheral mast cells and in human skin. Naunyn-Schemiederg's Arch Pharmacol 331:364-368, 1985.
19. Pearce FL, Kassenssionoff TA, Liu WL. Characteristics of histamine secretion induced by neuropeptides; implications for the relevance of peptide-mast cell interactions in allergy and inflammation. Int Arch Allergy Appl Immunol 88:129-131, 1989.
20. Anggard A. Basic mechanisms in autonomic nervous responses in specific and nonspecific nasal hyperreactivity. Acta Otolaryngol (Stockh) 113:394-396, 1993.
21. Braunstein G, Fajac I, Lacronique J, Frossard N. Clinical and inflammatory responses to exogenous tachykinins in allergic rhinitis. Am Rev Respir Dis 144:630-635, 1991.
22. Church MK, Gradidge CF. Oxatomide: Inhibition and stimulation of histamine release from human lung and leukocytes in vitro. Agents Actions 10:4-7, 1980.
23. Tasaka K, Akagi M, Mio M, et al. Inhibitory effects of oxatomide on intracellular Ca mobilization, Ca uptake and histamine release, using rat peritoneal mast cells. Int Arch Allergy Appl Immunol 83:348-353, 1987.
24. Fischer B, Schmutzler W. Inhibition by azelastine of the immunologically induced histamine release from isolated guinea pig mast cells. Arzneim-Forsch Drug Res 31:1193-1195, 1981.
25. Chand N, Pillar John, Diamantis W, Duane S. Inhibition of allergic histamine release by azelastine and selected antiallergic drugs from rabbit leukocytes. Int Arch Allergy Appl Immunol 77:451-455, 1985.
26. Aliakbari J, Sreedharan SP, Turck CW, Goetzl ED. Selective localization of vasoactive intestinal peptide and substance P in human eosinophils. Biochem Biophys Res Communications 148:1440-1445, 1987.